Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Influence of the Acidic Beverage Cola on the Absorption of the HCV Agent Velpatasvir in Healthy Volunteers Being Treated With the Proton Pump Inhibitor Omeprazole.

Next Previous
Trial Profile

Influence of the Acidic Beverage Cola on the Absorption of the HCV Agent Velpatasvir in Healthy Volunteers Being Treated With the Proton Pump Inhibitor Omeprazole.

Completed
Phase of Trial: Phase I

Latest Information Update: 29 Jan 2019

At a glance

  • Drugs Sofosbuvir/velpatasvir (Primary) ; Omeprazole
  • Indications Hepatitis C
  • Focus Pharmacokinetics
  • Acronyms COPA

    • Most Recent Events

    • 21 Jan 2019 Status changed from not yet recruiting to completed.
    • 04 May 2018 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Legal

Back to top